As an FDA action date quickly approaches for a gene therapy that Novartis snatched up last year, the biotech that is developing the treatment says it needs to more than double the size of its new manufacturing operations. AveXis now plans to have 400 empl
As a globally recognized leader in silicone-based technology for more than 60 years, Dow Silicones Corporation advances healthcare through material innovation